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Abstracts / Journal of Nutrition & Intermediary Metabolism 1 (2014) 1e5532mins, participants repeated the gut-challenge trial (GC2). Data were ana-
lysed by repeated measures ANOVA with post hoc and non-parametric
equivalents (Friedman) where appropriate.
Results: Overall GIS were lower in GC2 compared to GC1 (accumulated
rating: 86 cm vs. 508 cm; p < 0.05). Commonly reported GIS in GC1
included: belching, bloating, urge to vomit, stomach and intestinal pain,
ﬂatulence, urge to defecate and nausea; all subsiding in GC2. Taste fatigue
and tolerance to food-ﬂuid improved in GC2 compared to GC1 (p < 0.05).
Breath hydrogen was lower in GC2 compared to GC1 (AUC: 1500 ± 589
ppm/300 min vs. 2580 ± 704 ppm/300 min; p < 0.01), with no signiﬁcant
change in breath methane observed.
Conclusions: Findings suggest that 10-days’ of gut-challenge improves
GIS, food-ﬂuid intake ability and absorption during exertional stress. Ul-
timately, this may have substantial impact on exercise performance.
Funding source(s): N/A.
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Background/Aims: The mechanisms by which consumption of fructose
rich diets may be linked with elevated risk of developing obesity and
related chronic diseases remain debatable. Fructose-induced hyper-
lipidaemia and inﬂammation have been thought to mediate the adverse
health effects of fructose. This study aimed to investigate the effects of
dietary supplementation with fructose or glucose on blood lipids and low
grade inﬂammation in healthy subjects.
Methods: This was a two-arm, parallel-design, randomised dietary inter-
vention trial. Participants (n ¼ 24) were asked to supplement their usual
diets with 50 g of either fructose or glucose per day for a period of 4 weeks.
Blood samples were collected at baseline and post intervention for the
analysis of blood lipids, glucose, insulin and high sensitivity C-reactive
protein (hs-CRP). An independent-sample t-test was conducted to
compare the effects of fructose and glucose supplementation.
Results: Following dietary supplementationwith fructose or glucose there
was no signiﬁcant difference in fasting blood insulin, glucose, total
cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol, total/HDL
cholesterol ratio and hs-CRP levels (all p > 0.05). The change in blood
glucose, insulin, hs-CRP and lipid levels from baseline to post-intervention
with fructose versus glucose were also similar.
Conclusions: Type of sugar (fructose or glucose) consumed does not in-
ﬂuence blood lipid proﬁle, glycaemic indices and low grade inﬂammation
in healthy individuals.
Funding source(s): Hunter Medical Research Institute.
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Background/Aims: The aim of this study was to examine the efﬁcacy of
diets containing (-)-epigallocatechin-3-gallate (EGCG), curcumin (Curc),
DHA and a-lipoic acid (ALA) on reducing cognitive deﬁcits and brain beta-
amyloid (Ab) levels in a transgenic Alzheimer’s disease (AD) mouse model.
Methods: Sixty mice (age six months) were randomly assigned to one of
six nutritional supplement groups (Control, Curc, Curc+EGCG+ALA,
Curc+DHA+ALA, EGCG+DHA+ALA, Curc+EGCG+DHA+ALA) for 12 months.
At 18 months of age, the cognitive effects of the nutritional supplements
were evaluated behaviourally using the cued and contextual fearavoidance test. A commercially available assay was used for the detection
andmeasurement of Ab levels in the brain. Difference between groups was
tested using one-way ANOVA.
Results: All nutritional supplement groups had lower frontal cortex Ab42
levels compared to Controls (p < 0.05). Only the DHA+EGCG+ALA group
had reduced frontal cortex Ab40 levels compared to Controls (p < 0.05). No
differences were observed in cerebellum Ab42 levels, although the Cur-
c+EGCG+ALA and DHA+EGCG+ALA groups did have lower cerebellum Ab40
levels compared to Controls (p < 0.05). All nutritional supplement com-
bination groups had signiﬁcant increases in time spent freezing in the
context, altered context and auditory cue conditions in the cued and
contextual fear avoidance testing compared to Controls (p < 0.05).
Conclusions: The combination nutritional supplements in this study were
effective at lowering brain Ab42 levels and improving cognition. However
there does not appear to be additional beneﬁts from combinations of these
nutritional components over a single nutritional supplement of Curc.
Funding source(s): NHMRC.
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Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is an inde-
pendent predictor of CVD. n-3 PUFA supplementation has been shown to
improve NAFLD. This study aimed to examine the relationship of the
Omega-3 Index (O3I; a biomarker of n-3 status) with liver fat (intrahepatic
lipid concentration; IHL%).
Methods: Eighty overweight/obese, healthy, non-smoker adults (56
males) undertook MRI and proton magnetic resonance spectroscopy (1H-
MRS) to measure abdominal adiposity and IHL% within seven days of
undergoing anthropometric measurements and providing a blood sample
for biochemical and erythrocyte lipid analysis. Correlations with liver fat
were examined and linear regression for the prediction of IHL% was per-
formed. Mean ± SEM are reported.
Results: O3I was high in participants with (9.0 ± 0.3%) and without (8.4 ±
0.3%) NAFLD, and was positively correlated with IHL% (r ¼ 0.255, p ¼ 0.029),
although further analysis revealed this was stronger and statistically signif-
icant for males (r ¼ 0.425, p¼ 0.001) and not females (r¼ 0.020, p¼ 0.925).
Linear regression showed that O3I and erythrocyte n-6:n-3 ratio together
signiﬁcantlyexplained28%of thevariance in IHL% (p¼ 0.046). The additionof
BMI, waist and age raised the predictive power to 58% (p < 0.001). Further
addition of biochemical markers (TAG, HDL, high-sensitive C-reactive pro-
tein) increased the total variance explained by the model to 66%.
Conclusions: In overweight/obese adults, O3I was unexpectedly positively
associated with IHL%, however gender differences apparent in this cohort
warrant further research. In overweight obese adults, simple anthropo-
metric and demographic measures may be of equal or greater utility than
erythrocyte PUFA analysis in identifying those at increased risk of NAFLD.
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Background/Aims: Malnutrition in healthcare facilities remains an
ongoing challenge. Opportunities exist to develop the foodservice system
and engage this workforce to improve patient outcomes. The aim was to
determine the effect of changing the foodservice system on anthropom-
etry and patients’ satisfaction with the foodservice.
Methods: The intervention consisted of a high-energy hospital menu and
greater foodservice staff-patient interaction. Patients in subacute care
